Published in World J Nephrol on May 06, 2013
Influence of urate-lowering therapies on renal handling of uric acid. Clin Rheumatol (2014) 1.44
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.94
The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship. Biomed Res Int (2014) 0.88
Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment. Cardiorenal Med (2015) 0.80
Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review. PLoS One (2017) 0.77
Asymptomatic hyperuricemia following renal transplantation. World J Nephrol (2015) 0.75
Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1991) 7.26
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr (2007) 5.28
Clinical practice. Gout. N Engl J Med (2011) 4.44
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis (2006) 4.26
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol (2010) 4.06
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis (2004) 2.73
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens (2008) 2.42
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
The kidney in gout. Medicine (Baltimore) (1960) 2.21
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension (2011) 2.05
Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int (2005) 2.02
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol (2011) 1.85
Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol (2006) 1.83
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes (2009) 1.76
Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol (2005) 1.76
Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem (1997) 1.75
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.74
Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol (2003) 1.69
Molecular physiology of urate transport. Physiology (Bethesda) (2005) 1.69
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68
Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis (2010) 1.65
Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol (2002) 1.64
Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem (1997) 1.62
Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem (2000) 1.60
The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. Anadolu Kardiyol Derg (2009) 1.55
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem (1999) 1.48
Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant (2010) 1.45
Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant (2009) 1.42
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol (2001) 1.41
A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol (2011) 1.40
Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol (2007) 1.25
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol (2008) 1.25
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23
Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis (2010) 1.23
Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Transplantation (2008) 1.13
Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia. Nephrol Dial Transplant (2007) 1.13
Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol (1999) 1.10
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther (2002) 1.05
Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One (2011) 1.05
Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (2006) 1.02
Gout, diuretics and the kidney. Ann Rheum Dis (2006) 1.02
Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci (2006) 1.00
Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant (2011) 0.97
Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc (2007) 0.97
Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol (2009) 0.97
The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation (2010) 0.96
Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant (1999) 0.94
Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation (2005) 0.92
Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press Res (1998) 0.90
Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat Rev Nephrol (2011) 0.90
Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J Clin Hypertens (Greenwich) (2009) 0.90
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Des (2005) 0.88
Hyperuricemia, gout, and renal function after liver transplantation. Transplantation (2001) 0.88
Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Nutr Metab Cardiovasc Dis (2006) 0.84
Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Transplant Proc (2009) 0.84
Factors affecting the long-term renal allograft survival. Chin Med J (Engl) (2011) 0.83
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Am J Cardiol (2009) 0.82
Uric acid contributes to glomerular filtration rate deterioration in renal transplantation. Nephron Clin Pract (2010) 0.82
Hyperuricemia influences chronic cyclosporine nephropathy. Transplant Proc (2008) 0.81
The effect of hyperuricemia on endothelial biomarkers and renal function in kidney allograft recipients. Transplant Proc (2010) 0.78